Restricted accessReview articleFirst published online 2026-3
Expanding the scope of olfactory evaluation in Alzheimer's disease and related dementias (ADRD): A narrative review of the role for odor memory and recognition in AD/ADRD
Olfactory dysfunction (OD) is a well-characterized feature of Alzheimer's disease (AD) and is often one of the earliest functional biomarkers in the disease course. As such, olfactory evaluation shows promise as an important tool in AD screening and may provide insight into pathologic underpinnings and potential treatment pathways. The National Plan to Address Alzheimer's Disease emphasizes the importance of including Alzheimer's disease related dementias (ADRD) in research efforts, and while olfaction is also associated with ADRD, this association is relatively understudied. Additionally, there have been efforts to expand the evaluation of olfactory function to include assessments beyond key domains, such as odor threshold, odor discrimination, and odor identification, which have been the primary focus of most olfaction research in AD/ADRD. Odor recognition memory assessments have been developed primarily for their utility in identifying and stratifying individuals along the AD continuum, although a wide variety of methods have been reported in the literature. In this narrative review, we provide an overview of odor identification, odor threshold, and odor discrimination in AD/ADRD with a specific focus on providing a centralized guide detailing odor recognition memory methods and their utility in AD/ADRD.
Lafaille-MagnanM-EPoirierJEtienneP, et al.Odor identification as a biomarker of preclinical AD in older adults at risk. Neurology2017; 89: 327–335.
2.
DotyRLKamathV. The influences of age on olfaction: a review. Front Psychol2014; 5: 20.
3.
DanXWechterNGrayS, et al.Olfactory dysfunction in aging and neurodegenerative diseases. Ageing Res Rev2021; 70: 101416.
4.
MarinCVilasDLangdonC, et al.Olfactory dysfunction in neurodegenerative diseases. Curr Allergy Asthma Rep2018; 18: 42.
5.
LiuDLuJWeiL, et al.Olfactory deficit: a potential functional marker across the Alzheimer’s disease continuum. Front Neurosci2024; 18: 1309482.
6.
MurphyC. Olfactory and other sensory impairments in Alzheimer disease. Nat Rev Neurol2019; 15: 11–24.
7.
QuarmleyMMobergPJMechanic-HamiltonD, et al.Odor identification screening improves diagnostic classification in incipient Alzheimer’s disease. J Alzheimers Dis2016; 55: 1497–1507.
8.
JackCRAndrewsJSBeachTG, et al.Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup. Alzheimers Dement2024; 20: 5143–5169.
9.
WheelerPLMurphyC. Olfactory measures as predictors of conversion to mild cognitive impairment and Alzheimer’s disease. Brain Sci2021; 11: 1391.
10.
WalkerIMFullardMEMorleyJF, et al.Olfaction as an early marker of Parkinson’s disease and Alzheimer’s disease. Handb Clin Neurol2021; 182: 317–329.
11.
WoodwardMRAmrutkarCVShahHC, et al.Validation of olfactory deficit as a biomarker of Alzheimer disease. Neurol Clin Pract2017; 7: 5–14.
12.
DigheSJogSMominM, et al.Intranasal drug delivery by nanotechnology: advances in and challenges for Alzheimer’s disease management. Pharmaceutics2023; 16: 58.
13.
LiuMChenCYuanQ, et al.Olfactory bulb biosensor monitoring the effect of treatment drugs for ad in vitro. In: 2022 IEEE international symposium on olfaction and electronic nose (ISOEN). Piscataway, NJ: IEEE, 2022, pp.1–3.
14.
ChaHKimSSeoM, et al.Effects of olfactory stimulation on cognitive function and behavior problems in older adults with dementia: a systematic literature review. Geriatr Nurs (Minneap)2021; 42: 1210–1217.
15.
D’AndreaFTischlerVDeningT, et al.Olfactory stimulation for people with dementia: a rapid review. Dementia (London)2022; 21: 1800–1824.
DeTureMADicksonDW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener2019; 14: 32.
18.
BouhabenJDelgado-LimaAHDelgado-LosadaML. The role of olfactory dysfunction in mild cognitive impairment and Alzheimer’s disease: a meta-analysis. Arch Gerontol Geriatr2024; 123: 105425.
19.
De CleeneNSchwarzováKLabrecqueS, et al.Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review. Front Neurosci2024; 18: 1505029.
20.
LiuSJiangZZhaoJ, et al.Disparity of smell tests in Alzheimer’s disease and other neurodegenerative disorders: a systematic review and meta-analysis. Front Aging Neurosci2023; 15: 1249512.
21.
LiaoWWangYWangL, et al.The current status and challenges of olfactory dysfunction study in Alzheimer’s disease. Ageing Res Rev2024; 100: 102453.
22.
OuteiroTFKossDJErskineD, et al.Dementia with Lewy bodies: an update and outlook. Mol Neurodegener2019; 14: 5.
23.
BottNTRadkeAStephensML, et al.Frontotemporal dementia: diagnosis, deficits and management. Neurodegener Dis Manag2014; 4: 439–454.
24.
LintonAEWeekmanEMWilcockDM. Pathologic sequelae of vascular cognitive impairment and dementia sheds light on potential targets for intervention. Cereb Circ Cogn Behav2021; 2: 100030.
25.
YamashitaYShojiYYanagimotoH, et al.A characteristic of olfactory function in four types of dementia and non-dementia subjects using smell identification test. Psychogeriatrics2024; 24: 25–34.
26.
YamadaMKomatsuJNakamuraK, et al.Diagnostic criteria for dementia with Lewy bodies: updates and future directions. J Mov Disord2020; 13: 1–10.
27.
DotyRLHawkesCHGoodKP, et al.Odor perception and neuropathology in neurodegenerative diseases and schizophrenia. In: DotyRL (ed) Handbook of olfaction and gustation. Hoboken, NJ: John Wiley & Sons, Inc., 2015, pp.403–439.
28.
MurphyCNordinSAcostaL. Odor learning, recall, and recognition memory in young and elderly adults. Neuropsychology1997; 11: 126–137.
29.
FrankCMurphyC. The brief form of the California odor learning test 3. Front Neurosci2020; 14: 173.
30.
SeneviratneRWeinbornMBadcockDR, et al.The western Australia olfactory memory test: reliability and validity in a sample of older adults. Arch Clin Neuropsychol2022; 37: 1720–1734.
31.
BesserGJobsLLiuDT, et al.The Sniffin’ sticks odor discrimination memory test: a rapid, easy-to-use, reusable procedure for testing olfactory memory. Ann Otol Rhinol Laryngol2019; 128: 227–232.
32.
SorokowskaASabiniewiczALarssonM. TOM-32–An extended test for the assessment of olfactory memory. J Neurosci Methods2020; 344: 108873.
33.
LarssonM. Semantic factors in episodic recognition of common odors in early and late adulthood: a review. Chem Senses1997; 22: 623–633.
34.
MooreABPaulsenJSMurphyC. A test of odor fluency in patients with Alzheimer’s and Huntington’s disease. J Clin Exp Neuropsychol1999; 21: 341–351.
35.
RoyetJPHudryJZaldDH, et al.Functional neuroanatomy of different olfactory judgments. Neuroimage2001; 13: 506–519.
36.
HannumMEFryerJASimonsCT. Non-food odors and the duality of smell: impact of odorant delivery pathway and labeling convention on olfactory perception. Physiol Behav2021; 238: 113480.
37.
HannumMStegmanMAFryerJA, et al.Different olfactory percepts evoked by orthonasal and retronasal odorant delivery. Chem Senses2018; 43: 515–521.
38.
SavvoulidouDTotikidouEVarvesiotouC, et al.The brief odor detection test (B-ODT) for very early diagnosis of cognitive decline: a preliminary study. Brain Impair2017; 18: 197–210.
39.
HummelTWhitcroftKLAndrewsP, et al.Position paper on olfactory dysfunction. Rhinol J2017; 54: 1–30.
40.
KovalováMGottfriedováNMrázkováE, et al.Cognitive impairment, neurodegenerative disorders, and olfactory impairment: a literature review. Otolaryngol Pol2024; 78: 1–17.
41.
DotyRLShamanPKimmelmanCP, et al.University of Pennsylvania smell identification test: a rapid quantitative olfactory function test for the clinic. Laryngoscope1984; 94: 176–178.
42.
DotyRLMarcusALeeWW. Development of the 12-item cross-cultural smell identification test (CC-SIT). Laryngoscope1996; 106: 353–356.
43.
HummelTSekingerBWolfSR, et al.Sniffin’ sticks’: olfactory performance assessed by the combined testing of odour identification, odor discrimination and olfactory threshold. Chem Senses1997; 22: 39–52.
44.
JiangR-SLiangK-L. A pilot study of the snap & sniff threshold test. Ann Otol Rhinol Laryngol2018; 127: 312–316.
45.
CardesínAAlobidIBenítezP, et al.Barcelona smell test - 24 (BAST-24): validation and smell characteristics in the healthy spanish population. Rhinology2006; 44: 83–89.
46.
CainWSGentJFGoodspeedRB, et al.Evaluation of olfactory dysfunction in the Connecticut chemosensory clinical research center. Laryngoscope1988; 98: 83–88.
47.
SaikiKFukazawaOAsakaH, et al.T & T olfactometer for standardized olfactory test and its uses. In: KuriharaKSuzukiNOgawaH (eds) Olfaction and taste XI. Tokyo: Springer Japan, 1994, pp.340–340.
48.
DaltonPDotyRLMurphyC, et al. Olfactory assessment using the NIH toolbox. Neurology2013; 80: S32–S36.
49.
VodickaJPellantAChrobokV. Screening of olfactory function using odourized markers. Rhinology2007; 45: 164–168.
50.
OkutaniFHiroseKKobayashiT, et al.Evaluation of “open essence” odor-identification test card by application to healthy volunteers. Auris Nasus Larynx2013; 40: 76–80.
51.
DuffKMcCaffreyRJSolomonGS. The pocket smell test: successfully discriminating probable Alzheimer’s dementia from vascular dementia and major depression. J Neuropsychiatry Clin Neurosci2002; 14: 197–201.
52.
JackmanAHDotyRL. Utility of a three-item smell identification test in detecting olfactory dysfunction. Laryngoscope2005; 115: 2209–2212.
53.
MurphyCAndersonJAMarkisonS. Psychophysical assessment of chemosensory disorders in clinical populations. In: KuriharaKSuzukiNOgawaH (eds) Olfaction and taste XI. Tokyo: Springer Japan, 1994, pp.609–613.
54.
NordinSBrämersonALidénE, et al.The scandinavian odor-identification test: development, reliability, validity and normative data. Acta Otolaryngol1998; 118: 226–234.
55.
BrinerHRSimmenD. Smell diskettes as screening test of olfaction. Rhinology1999; 37: 145–148.
56.
JungHJShinILeeJ. Olfactory function in mild cognitive impairment and Alzheimer’s disease: a meta-analysis. Laryngoscope2019; 129: 362–369.
NicholsEMerrickRHaySI, et al.The prevalence, correlation, and co-occurrence of neuropathology in old age: harmonisation of 12 measures across six community-based autopsy studies of dementia. Lancet Healthy Longev2023; 4: e115–e125.
59.
RahayelSFrasnelliJJoubertS. The effect of Alzheimer’s disease and Parkinson’s disease on olfaction: a meta-analysis. Behav Brain Res2012; 231: 60–74.
60.
SilvaMMEMercerPBSWittMCZ, et al.Olfactory dysfunction in Alzheimer’s disease: systematic review and meta-analysis. Dement Neuropsychol2018; 12: 123–132.
61.
TonacciABilleciL. Olfactory testing in frontotemporal dementia: a literature review. Am J Alzheimers Dis Other Demen2018; 33: 342–352.
62.
TonacciABilleciLTartariscoG, et al.A novel application for cognitive evaluation in mountain ultramarathons: olfactory assessment. Wilderness Environ Med2016; 27: 131–135.
63.
TonacciAChilosiAMPioggiaG, et al.Effect of olfactory stimulation in agenesis of the corpus callosum: a case report. Brain Impair2014; 15: 216–222.
64.
OleszkiewiczASchrieverVACroyI, et al.Updated Sniffin’ sticks normative data based on an extended sample of 9139 subjects. Eur Arch Otorhinolaryngol2019; 276: 719–728.
65.
ContiMZVicini-ChiloviBRivaM, et al.Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer’s disease. Arch Clin Neuropsychol2013; 28: 391–399.
66.
DinticaCSHaaksmaMLOlofssonJK, et al.Joint trajectories of episodic memory and odor identification in older adults: patterns and predictors. Aging2021; 13: 17080–17096.
67.
KnightJEBennettDAPiccininAM. Variability and coupling of olfactory identification and episodic memory in older adults. J Gerontol B Psychol Sci Soc Sci2020; 75: 577–584.
68.
KnightJEYonedaTLewisNA, et al.Transitions between mild cognitive impairment, dementia, and mortality: the importance of olfaction. J Gerontol A Biol Sci Med Sci2023; 78: 1284–1291.
69.
DevanandDPLiuXTabertMH, et al.Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer’s disease. Biol Psychiatry2008; 64: 871–879.
70.
DjordjevicJJones-GotmanMDe SousaK, et al.Olfaction in patients with mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging2008; 29: 693–706.
71.
AudronyteEPakulaite-KazlieneGSutnikieneV, et al.Odor discrimination as a marker of early Alzheimer’s disease. J Alzheimers Dis2023; 94: 1169–1178.
72.
CarnemollaSEHsiehJWSipioneR, et al.Olfactory dysfunction in frontotemporal dementia and psychiatric disorders: a systematic review. Neurosci Biobehav Rev2020; 118: 588–611.
73.
SilvaMDMEViveirosCPKotsifasNJE, et al.Olfactory impairment in frontotemporal dementia: a systematic review and meta-analysis. Dement Neuropsychol2019; 13: 154–161.
74.
BochniakKSoszyńskiMMadetko-AlsterN, et al.Current perspectives on olfactory loss in atypical parkinsonisms—a review article. Biomedicines2024; 12: 2257.
75.
Torres-PasillasGChi-CastañedaDCarrillo-CastillaP, et al.Olfactory dysfunction in Parkinson’s disease, its functional and neuroanatomical correlates. NeuroSci2023; 4: 134–151.
McKeithIGBoeveBFDicksonDW, et al.Diagnosis and management of dementia with Lewy bodies. Neurology2017; 89: 88–100.
78.
LiberiniPParolaSSpanoPF, et al.Olfaction in Parkinson’s disease: methods of assessment and clinical relevance. J Neurol2000; 247: 88–96.
79.
OlichneyJMMurphyCHofstetterCR, et al.Anosmia is very common in the Lewy body variant of Alzheimer’s disease. J Neurol Neurosurg Psychiatry2005; 76: 1342–1347.
80.
FoguemCLemdaniMHuartC. Nasal chemosensory tests: biomarker between dementia with Lewy bodies and Parkinson disease dementia. Rhinology2020; 58: 605–609.
81.
TsopelasCStewartRSavvaGM, et al.Neuropathological correlates of late-life depression in older people. Br J Psychiatry2011; 198: 109–114.
82.
RossGWAbbottRDPetrovitchH, et al.Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord2006; 21: 2062–2067.
83.
AbbottRDRossGWPetrovitchH, et al.Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord2007; 22: 1581–1586.
84.
MiyamotoTMiyamotoMIwanamiM, et al.Olfactory dysfunction in idiopathic REM sleep behavior disorder. Sleep Med2010; 11: 458–461.
85.
MiyamotoT. Olfactory dysfunction in Parkinson disease and REM sleep behavior disorder. Brain Nerve2012; 64: 356–363.
86.
KrismerFPinterBMuellerC, et al.Sniffing the diagnosis: olfactory testing in neurodegenerative parkinsonism. Parkinsonism Relat Disord2017; 35: 36–41.
87.
MiyamotoTMiyamotoM. Phenoconversion from idiopathic rapid eye movement sleep behavior disorder to Lewy body disease. Mov Disord Clin Pract2018; 5: 506–511.
88.
MiyamotoTMiyamotoM. Odor identification predicts the transition of patients with isolated RBD: a retrospective study. Ann Clin Transl Neurol2022; 9: 1177–1185.
89.
MahlknechtPIranzoAHöglB, et al.Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD. Neurology2015; 84: 654–658.
90.
AlbertMSDeKoskySTDicksonD, et al.The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement2011; 7: 270–279.
91.
AlvesJPetrosyanAMagalhaesR. Olfactory dysfunction in dementia. World J Clin Cases2014; 2: 661.
92.
KnupferLSpiegelR. Differences in olfactory test performance between normal aged, Alzheimer and vascular type dementia individuals. Int J Geriatr Psychiatry1986; 1: 3–14.
93.
GrayAJStaplesVMurrenK, et al.Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type. Int J Geriatr Psychiatry2001; 16: 513–517.
94.
DinticaCSMarsegliaARizzutoD, et al.Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain. Neurology2019; 92: E700–E709.
95.
JobinBBollerBFrasnelliJ. Volumetry of olfactory structures in mild cognitive impairment and Alzheimer’s disease: a systematic review and a meta-analysis. Brain Sci2021; 11: 1010.
96.
TianQBilgelMMoghekarAR, et al.Olfaction, cognitive impairment, and PET biomarkers in community-dwelling older adults. J Alzheimers Dis2022; 86: 1275–1285.
97.
FrasnelliJLundströmJNBoyleJA, et al.Neuroanatomical correlates of olfactory performance. Exp Brain Res2010; 201: 1–11.
98.
ChenZChangFYaoL, et al.Clinical significance of the cognition-related pathogenic proteins in plasma neuronal-derived exosomes among normal cognitive adults over 45 years old with olfactory dysfunction. Eur Arch Otorhinolaryngol2022; 279: 3467–3476.
99.
DevanandDP. Olfactory identification deficits, cognitive decline, and dementia in older adults. Am J Geriatr Psychiatry2016; 24: 1151–1157.
100.
SonGJahanshahiAYooS-J, et al.Olfactory neuropathology in Alzheimer’s disease: a sign of ongoing neurodegeneration. BMB Rep2021; 54: 295–304.
101.
MurphyCCainWSGilmoreMM, et al.Sensory and semantic factors in recognition memory for odors and graphic stimuli: elderly versus young persons. Am J Psychol1991; 104: 161–192.
102.
LehrnerJP. Gender differences in long-term odor recognition memory: verbal versus sensory influences and the consistency of label use. Chem Senses1993; 18: 17–26.
103.
NordinSMurphyC. Impaired sensory and cognitive olfactory function in questionable Alzheimer’s disease. Neuropsychology1996; 10: 113–119.
104.
LehrnerJPBruckeTDai-BiancoP, et al.Olfactory functions in Parkinson’s disease and Alzheimer’s disease. Chem Senses1997; 22: 105–110.
105.
MurphyCNordinS. Odor learning, recall, and recognition memory in young and elderly adults. Neuropsychology1997; 11: 126–137.
106.
DelisDCKramerJHKaplanE, et al.The California verbal learning test: Research edition. Washington, DC: APA PsycTests, 2017.
107.
Niccoli-WallerCAHarveyJNordinS, et al.Remote odor memory in Alzheimer’s disease: deficits as measured by familiarity. J Adult Dev1999; 6: 131–136.
108.
GilbertPEBarrPJMurphyC. Differences in olfactory and visual memory in patients with pathologically confirmed Alzheimer’s disease and the Lewy body variant of Alzheimer’s disease. J Int Neuropsychol Soc2004; 10: 835–842.
109.
SundermannEGilbertPEMurphyC. Estrogen and performance in recognition memory for olfactory and visual stimuli in females diagnosed with Alzheimer’s disease. J Int Neuropsychol Soc2006; 12: 400–404.
110.
SundermannEEGilbertPEMurphyC. Apolipoprotein E 4 genotype and gender: effects on memory. Am J Geriatri Psychiatry2007; 15: 869–878.
111.
MurphyCSolomonESHaaseL, et al.Olfaction in aging and Alzheimer’s disease: event-related potentials to a cross-modal odor-recognition memory task discriminate ApoE ε4+and ApoE ε4- individuals. Ann N Y Acad Sci2009; 1170: 647–657.
112.
Bahar-FuchsAMossSRoweC, et al.Olfactory performance in AD, aMCI, and healthy ageing: a unirhinal approach. Chem Senses2010; 35: 855–862.
113.
GreenAJMelissaCGravesLV, et al.Age and apolipoprotein E ε4 effects on neural correlates of odor memory. Behav Neurosci2013; 127: 339–349.
114.
SzajerJMurphyC. Education level predicts retrospective metamemory accuracy in healthy aging and Alzheimers disease. J Clin Exp Neuropsychol2013; 35: 971–982.
115.
NaudinMMondonKEl-HageW, et al.Long-term odor recognition memory in unipolar major depression and Alzheimer’s disease. Psychiatry Res2014; 220: 861–866.
116.
CroyIZehnerCLarssonM, et al.Test-retest reliability and validity of the sniffin’ TOM odor memory test. Chem Senses2015; 40: 173–179.
117.
LarssonMHednerMPapenbergG, et al.Olfactory memory in the old and very old: relations to episodic and semantic memory and APOE genotype. Neurobiol Aging2016; 38: 118–126.
118.
Dhilla AlbersAAsafu-AdjeiJDelaneyMK, et al.Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly. Ann Neurol2016; 80: 846–857.
119.
El HajMGandolpheMCGalloujK, et al.From nose to memory: the involuntary nature of odor-evoked autobiographical memories in Alzheimer’s disease. Chem Senses2018; 43: 27–34.
120.
BowerESSzajerJMurphyC. Effect of worry level on recall memory for odors in ApoE-I4 carriers and non-carriers. J Int Neuropsychol Soc2019; 25: 546–556.
121.
GlachetOEl HajM. Emotional and phenomenological properties of odor-evoked autobiographical memories in Alzheimer’s disease. Brain Sci2019; 9: 135.
122.
KapouleaEAMurphyC. Older, non-demented apolipoprotein ε4 carrier males show hyperactivation and structural differences in odor memory regions: a blood-oxygen-level-dependent and structural magnetic resonance imaging study. Neurobiol Aging2020; 93: 25–34.
123.
AudronyteESutnikieneVPakulaite-KazlieneG, et al.Olfactory memory in mild cognitive impairment and Alzheimer’s disease. Front Neurol2023; 14: 1165594.
124.
HajMEGlachetOMoustafaAA, et al.The smell of my self: odor exposure increases the number of self-defining memories in Alzheimer’s disease. Curr Psychol2023; 42: 7031–7037.
125.
CainWS. To know with the nose: keys to odor identification. Science1979; 203: 467–470.
126.
SorokowskaAKarwowskiM. No sensory compensation for olfactory memory: differences between blind and sighted people. Front Psychol2017; 8: 2127.
127.
JobinBMagdamoCDelphusD, et al.The AROMHA brain health test is a remote olfactory assessment to screen for cognitive impairment. Sci Rep2025; 15: 9290.
128.
Corriveau-LecavalierNAdamsJNFischerL, et al.Cerebral hyperactivation across the Alzheimer’s disease pathological cascade. Brain Commun2024; 6: fcae376.
129.
DelisDCKramerJHKaplanE, et al.California verbal learning test, third edition. Washington, DC: PsycTESTS Dataset, 2022.
DotyRLMckeownDALeeWW, et al.A study of the test-retest reliability of ten olfactory tests. Chem Senses1995; 20: 645–656.
132.
ElsnerRJ. Odor threshold, recognition, discrimination and identification in centenarians. Arch Gerontol Geriatr2001; 33: 81–94.
133.
ChoudhuryESMobergPDotyRL. Influences of age and sex on a microencapsulated odor memory test. Chem Senses2003; 28: 799–805.
134.
HarveyPD. Domains of cognition and their assessment. Dialogues Clin Neurosci2019; 21: 227–237.
135.
XuPChenALiY, et al.Medial prefrontal cortex in neurological diseases. Physiol Genomics2019; 51: 432–442.
136.
HaszBMRedishAD. Dorsomedial prefrontal cortex and hippocampus represent strategic context even while simultaneously changing representation throughout a task session. Neurobiol Learn Mem2020; 171: 107215.
137.
Takehara-NishiuchiK. Entorhinal cortex and consolidated memory. Neurosci Res2014; 84: 27–33.
138.
HermansEJBattagliaFPAtsakP, et al.How the amygdala affects emotional memory by altering brain network properties. Neurobiol Learn Mem2014; 112: 2–16.
139.
RaoYLGanarajaBMurlimanjuBV, et al.Hippocampus and its involvement in Alzheimer’s disease: a review. 3 Biotech2022; 12: 55.
140.
GrandeGVallettaMRizzutoD, et al.Blood-based biomarkers of Alzheimer’s disease and incident dementia in the community. Nat Med2025; 31: 2027–2035.
141.
ShresthaSZhuXGriswoldME, et al.Olfaction and plasma biomarkers of Alzheimer disease and neurodegeneration in the atherosclerosis risk in communities study. Neurology2025; 104: e213706.
142.
LeuzyACullenNCMattsson-CarlgrenN, et al.Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer’s disease. Curr Opin Neurol2021; 34: 266–274.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
